CD274 and neoplasm: However, there are limited data evaluating any potential prognostic value of tumor PD-L1 expression [30] in patients receiving SOC therapy (i.e., nonimmunotherapeutic treatments, particularly those with less frequently occurring tumor types such as those included in this study).